Company intelligence / Profile preview

FlowMedica

Fremont, California, United Statesinvestors.angiodynamics.com ↗

Ownership: Private
Development stage: Other

Overview

FlowMedica developed and commercialized FDA 510(k)-cleared and CE-marked catheter-based infusion systems for targeted renal therapy. These systems enabled direct delivery of therapeutic agents to the kidneys via the renal arteries, aiming to prevent and treat kidney dysfunction in high-risk patients. The company’s Benephit® product line was used clinically for conditions such as contrast-induced nephropathy and acute kidney injury.

Therapeutic areas: NephrologyCardiovascular
Modalities: DeviceDrug delivery system (catheter-based)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on FlowMedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FlowMedica.

Explore the full profile